Aspira Women's Health Inc.
AWHL
$0.16
$0.00382.43%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.85% | 10.28% | 1.80% | -2.73% | -7.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.85% | 10.28% | 1.80% | -2.73% | -7.04% |
| Cost of Revenue | -23.43% | -5.60% | -0.88% | 6.48% | -16.90% |
| Gross Profit | 28.50% | 22.15% | 3.67% | -8.32% | 2.36% |
| SG&A Expenses | -23.83% | 2.91% | -5.53% | -6.12% | -18.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.58% | -7.74% | -5.24% | 0.06% | -20.16% |
| Operating Income | 31.21% | 17.03% | 9.04% | -1.67% | 25.00% |
| Income Before Tax | 59.97% | 55.07% | 24.63% | -52.35% | 29.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 59.97% | 55.07% | 24.63% | -52.35% | 29.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.97% | 55.07% | 24.63% | -52.35% | 29.63% |
| EBIT | 31.21% | 17.03% | 9.04% | -1.67% | 25.00% |
| EBITDA | 31.06% | 16.62% | 8.71% | -2.30% | 24.62% |
| EPS Basic | 78.05% | 72.04% | 52.18% | -2.25% | 50.61% |
| Normalized Basic EPS | 78.05% | 42.75% | 52.18% | 28.61% | 50.63% |
| EPS Diluted | 78.05% | 72.04% | 52.18% | -2.25% | 50.61% |
| Normalized Diluted EPS | 78.05% | 42.75% | 52.18% | 28.61% | 50.63% |
| Average Basic Shares Outstanding | 82.26% | 60.60% | 57.58% | 49.03% | 42.50% |
| Average Diluted Shares Outstanding | 82.26% | 60.60% | 57.58% | 49.03% | 42.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |